Decrease of circARID1A retards glioblastoma invasion by modulating miR-370-3p/ TGFBR2 pathway

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma (GBM) is a highly aggressive brain tumor with poor prognosis.
• Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer development.
• The specific functions of circRNAs in GBM progression remain largely unexplored.

Purpose of the Study:

• To investigate the role of circRNAs in glioblastoma (GBM) biological activity.
• To identify specific circRNAs involved in GBM proliferation and invasion.
• To elucidate the molecular mechanisms underlying circRNA-mediated GBM progression.

Main Methods:

• CircRNA array analysis identified differentially expressed circRNAs in GBM.
• Functional assays (e.g., cell migration, invasion) were performed to assess circARID1A's impact.
• Molecular techniques including dual-luciferase reporter assays, RNA pull-down, and FISH were used to determine molecular interactions.
• In vivo studies evaluated the effect of circARID1A silencing on GBM growth.
• Exosome analysis investigated circARID1A localization.

Main Results:

• circARID1A was significantly upregulated in GBM tissues and cell lines.
• Silencing circARID1A inhibited GBM cell migration and invasion.
• circARID1A was found to directly bind to miR-370-3p.
• The miR-370-3p/TGFBR2 pathway was identified as a key mediator of circARID1A's effects.
• circARID1A promoted GBM cell migration and invasion by modulating the miR-370-3p/TGFBR2 pathway.
• Silencing circARID1A suppressed GBM growth in vivo.
• circARID1A was detected in GBM cell-derived exosomes.

Conclusions:

• circARID1A plays a crucial role in promoting GBM cell migration and invasion.
• The circARID1A/miR-370-3p/TGFBR2 axis represents a novel regulatory pathway in GBM.
• circARID1A holds potential as a diagnostic biomarker for GBM, possibly detectable in serum via exosomes.